Matches in Wikidata for { <http://www.wikidata.org/entity/Q93182838> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q93182838 description "article scientifique publié en 2020" @default.
- Q93182838 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93182838 description "scientific article published on 20 April 2020" @default.
- Q93182838 description "wetenschappelijk artikel" @default.
- Q93182838 description "наукова стаття, опублікована 20 квітня 2020" @default.
- Q93182838 name "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 name "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 type Item @default.
- Q93182838 label "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 label "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 prefLabel "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 prefLabel "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 P1433 Q93182838-29841360-6E94-4625-83C4-B0EE1545D61A @default.
- Q93182838 P1476 Q93182838-2A6704EF-2806-46DB-8F86-D3BABD499104 @default.
- Q93182838 P2093 Q93182838-075AA27E-FB31-401A-9FBA-B48D2189D011 @default.
- Q93182838 P2093 Q93182838-0DA15C57-11CE-4271-8968-60C5B5A64D45 @default.
- Q93182838 P2093 Q93182838-17288FE2-0A16-45CE-8A12-13DB978C5FDE @default.
- Q93182838 P2093 Q93182838-19DBDF89-5A4E-40C3-95E0-CFCAB914E953 @default.
- Q93182838 P2093 Q93182838-1D2E05B5-F993-45EC-BADC-3444E15A8DC8 @default.
- Q93182838 P2093 Q93182838-2803989B-DA37-4438-9365-346B42F5ECF5 @default.
- Q93182838 P2093 Q93182838-2A812AF9-62FA-479A-AD48-E881CD6753A0 @default.
- Q93182838 P2093 Q93182838-2EEBE493-7169-489A-9AB3-BA0536E02C8A @default.
- Q93182838 P2093 Q93182838-3AF97BD0-8314-43D9-8947-B388F0390889 @default.
- Q93182838 P2093 Q93182838-40B0EEB6-CDCB-4ABB-A346-9B6C35C737DD @default.
- Q93182838 P2093 Q93182838-43377DFA-EA49-48F0-9DA8-6A588C578D83 @default.
- Q93182838 P2093 Q93182838-43849892-A006-4568-AE7E-425D8BCC56FE @default.
- Q93182838 P2093 Q93182838-461BB84C-F2D1-4F04-BC63-511D8EFFBDCD @default.
- Q93182838 P2093 Q93182838-4C397B85-6E9D-4E7A-9ED7-FA6C7BF02583 @default.
- Q93182838 P2093 Q93182838-4E4E92B9-D2BB-4DAA-8EC2-D843C6A54E42 @default.
- Q93182838 P2093 Q93182838-52B3B250-720B-432A-B078-576972BE6C3E @default.
- Q93182838 P2093 Q93182838-5E2A99F6-C7FA-4EA8-9652-8F46A7EC7E59 @default.
- Q93182838 P2093 Q93182838-8BE459A9-DBCB-4BE5-98D5-6ED1D95945DD @default.
- Q93182838 P2093 Q93182838-9CEE3145-3BA7-4E91-BCA6-C410385052BA @default.
- Q93182838 P2093 Q93182838-9DF69653-D340-4884-AEBB-3C6C91710DFD @default.
- Q93182838 P2093 Q93182838-AB2D6968-F991-416A-B787-BDD1EB27976E @default.
- Q93182838 P2093 Q93182838-C856000C-4541-4E06-9751-CBB370DBC2FE @default.
- Q93182838 P2093 Q93182838-CC1EC12E-2B5D-40ED-B6B7-5D5FC12D923A @default.
- Q93182838 P2093 Q93182838-D012EDCB-E9CB-4CA1-8835-2CBD76B1B5C9 @default.
- Q93182838 P2093 Q93182838-E2555F03-5D67-4AFE-B65A-0E4389D0EEDA @default.
- Q93182838 P2093 Q93182838-E44380F3-B34A-4E47-A087-D056DDB86964 @default.
- Q93182838 P304 Q93182838-17368FDC-327A-4E72-B813-5F51F96C1E55 @default.
- Q93182838 P31 Q93182838-AD6FBE94-7B67-44E9-838E-B14DE48826E3 @default.
- Q93182838 P356 Q93182838-F6A742A7-A4C6-434F-A81E-42BE0B0678F3 @default.
- Q93182838 P478 Q93182838-D7CEBB4B-3B0D-4EC3-A2BE-F602E802EDA6 @default.
- Q93182838 P577 Q93182838-CF4C44BB-F8BC-46DE-90C8-CC71575DC594 @default.
- Q93182838 P698 Q93182838-528358EA-292B-4C7D-9ABB-113B7E828BE7 @default.
- Q93182838 P356 J.EJCA.2020.03.018 @default.
- Q93182838 P698 32325419 @default.
- Q93182838 P1433 Q332260 @default.
- Q93182838 P1476 "Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)" @default.
- Q93182838 P2093 "Andreas L Petzer" @default.
- Q93182838 P2093 "Angelika Pichler" @default.
- Q93182838 P2093 "Austrian Breast & Colorectal Cancer Study Group" @default.
- Q93182838 P2093 "Christian F Singer" @default.
- Q93182838 P2093 "Christoph Tinchon" @default.
- Q93182838 P2093 "Daniel Egle" @default.
- Q93182838 P2093 "Edgar Petru" @default.
- Q93182838 P2093 "Florian Fitzal" @default.
- Q93182838 P2093 "Georg Pfeiler" @default.
- Q93182838 P2093 "Herbert Stöger" @default.
- Q93182838 P2093 "Margaretha Rudas" @default.
- Q93182838 P2093 "Marija Balic" @default.
- Q93182838 P2093 "Martin Filipits" @default.
- Q93182838 P2093 "Michael Gnant" @default.
- Q93182838 P2093 "Michael Hubalek" @default.
- Q93182838 P2093 "Muy-Kheng Maria Tea" @default.
- Q93182838 P2093 "Paul Sevelda" @default.
- Q93182838 P2093 "Peter C Dubsky" @default.
- Q93182838 P2093 "Raimund Jakesz" @default.
- Q93182838 P2093 "Richard Greil" @default.
- Q93182838 P2093 "Rupert Bartsch" @default.
- Q93182838 P2093 "Ruth Exner" @default.
- Q93182838 P2093 "Sophie Frantal" @default.
- Q93182838 P2093 "Vesna Bjelic-Radisic" @default.
- Q93182838 P2093 "Viktor Wette" @default.
- Q93182838 P2093 "Zsuzsanna Bago-Horvath" @default.
- Q93182838 P304 "43-52" @default.
- Q93182838 P31 Q13442814 @default.
- Q93182838 P356 "10.1016/J.EJCA.2020.03.018" @default.
- Q93182838 P478 "132" @default.
- Q93182838 P577 "2020-04-20T00:00:00Z" @default.
- Q93182838 P698 "32325419" @default.